Related Experiment Videos
Summary
Human uterine progestin receptors translocate from cytosol to nucleus, facilitated by specific cytosol treatments. Norethindrone (NET) is proposed as an effective tag for studying these progestin receptors.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- The human uterine progestin receptor facilitates the action of progestins.
- Understanding receptor translocation is crucial for comprehending progestin-mediated effects.
Purpose of the Study:
- To characterize the translocation of human uterine progestin receptors from cytosol to nucleus.
- To evaluate different progestins as tags for studying receptor dynamics.
Main Methods:
- A cell-free system was employed using radiolabeled progesterone ([3H]P), norethindrone ([3H]NET), and norethindrone acetate ([3H]NETA).
- Cytosol treatments (warming, salt concentration, protein dilution) were used to assess their effect on nuclear translocation.
- Physicochemical properties of nuclear-bound receptors were analyzed via gel chromatography, sedimentation, and isoelectric focusing.
Main Results:
- Nuclear binding required uterine cytosol; cytosol treatments enhanced receptor affinity for the nucleus.
- Nuclear receptors exhibited common physicochemical properties (mol wt 72,000, 4.2S, pI 5.3–5.6).
- Binding site concentrations were higher in proliferative (3780–4480 molecules/cell) versus secretory phase tissues (1790–1920 molecules/cell).
- High-affinity binding was observed (NET Kd ~0.7–0.8 nM, P Kd ~0.9–1.2 nM, NETA Kd ~6.7–7.1 nM).
- NET and NETA showed slower dissociation rates than P and did not bind corticosteroid-binding globulin.
Conclusions:
- Progestins act via a common receptor that translocates from cytosol to nucleus.
- Norethindrone (NET) is a suitable progestin receptor tag due to its distinct binding characteristics and advantages.